LOUISVILLE, Ky.--(BUSINESS WIRE)--Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to advancing novel therapeutics for the prevention and treatment of cancer, today announced the appointment of Robert W. Rounsavall, III to the company’s board of directors.
